User menu

Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study).

Bibliographic reference Coiffier, B. ; Mounier, N. ; Bologna, S. ; Ferme, C ; Herbrecht, R. ; et. al. Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study)..44th Annual Meeting of the American-Society-of-Hematology (PHILADELPHIA(Pennsylvania), Dec 06-10, 2002). In: Blood, Vol. 100, no. 11, p. 359A (2002)
Permanent URL http://hdl.handle.net/2078.1/61657